USA – First successful patient case
The first successful patient case using the LiVac™ Retractor has taken place in the USA.
Contact : +61 413 227 332 
News & Articles
Series B capital raise now open
Livac Pty Ltd would like to announce to its extended network that its series B funding round is now open to investors.
Livac obtains hospital approvals in Korea and USA
Recently appointed distributors in Korea and the US have been successful in obtaining hospital approvals for LiVac clinical evaluations with clinical utility in Korea already underway.
Livac appoints experienced device consultants
Livac is delighted to welcome two new members to its team – Carley Kercheval, as clinical trainer, and Phil Nowell, a Director of Ontogo, as a strategic advisor.
Livac welcomes new directors to board
Livac Holding Co. Pty Ltd is pleased to advise it has appointed two new directors to the Board – David Catterall and Amrit Bahra from corporate advisory group DashCap Advisory.
Melbourne-based medtech company LiVac values Melbourne’s thriving Startup Ecosystem
Livac CEO and ATC alumna Dr Anabela Correia is interviewed by Impact Tech Ventures for the Australian Technologies Competition newsletter.